电生理市场 - 全球产业规模、份额、趋势、机会及预测（按产品、适应症、最终用户、地区和竞争格局划分），2021-2031年

全球电生理市场预计将从 2025 年的 93.8 亿美元成长到 2031 年的 191.1 亿美元，复合年增长率达到 12.59%。

电生理学是心臟病学的一个分支，它透过分析心臟的电活动来诊断和治疗心律不整。此领域主要利用诊断导管、消融导管和标测系统来矫正心房颤动等心律不整，并恢復正常的心臟功能。全球人口老化和需要介入治疗的慢性心臟疾病患者数量不断增加，是推动该领域发展的主要因素。例如，心律学会 (HRS) 估计，到 2025 年，美国将有约 1,050 万成年人患有心房颤动，这意味着需要接受电生理治疗的患者群体将显着扩大。

然而，阻碍该市场快速扩张的主要障碍是熟练的电生理学家和执行这些复杂手术所需的专业人员短缺。掌握消融技术需要漫长的培训，造成了人才瓶颈，限制了医疗机构每年可进行的手术数量。合格人员的短缺限制了患者获得救命治疗的机会，也限制了全球製造商和医疗保健提供者的潜在收入成长。

市场驱动因素

心房颤动（心房颤动）和心律不整的日益普遍是全球电生理市场的主要驱动力。人口结构的变化，包括全球人口老化和高血压等生活方式相关风​​险因素的增加，正在推动复杂心律不整发病率的激增。患者群体的扩大导致对诊断和治疗性介入的需求增加，进而推动了对先进消融导管和标测系统的需求。根据Medtronic2024年5月发布的关于其PulseSelect脉衝电场消融系统在日本核准的新闻稿，全球有超过6000万人患有房颤，这凸显了全球范围内对有效电生理解决方案的迫切需求。

同时，持续的产品创新和关键监管核准正在提升手术的安全性和效率，加速市场扩张。脉衝电场消融（PFA）技术的近期商业化标誌着一个关键转折点，促使医疗机构迅速采用该技术以优化临床疗效和患者周转率。随着医院升级其检查室，这波创新浪潮正转化为领先製造商的显着收入成长。例如，波士顿科学公司在2024年10月发布的「2024年第三季财务与业绩亮点」报告中指出，其电生理业务净销售额年增177%，这主要得益于其新型消融产品组合的强劲表现。同样，雅培公司的电生理部门在2024年第三季实现了14.3%的有机销售额成长，进一步印证了该产业的上升趋势。

市场挑战

熟练的电生理医师和专业检查室人员短缺是限制市场成长的主要因素。电生理手术，尤其是消融和标测等手术，技术难度极高，需要操作人员接受广泛而深入的培训，以确保病人安全和手术成功。这种陡峭的学习曲线造成了劳动力供应的严重瓶颈，因为新入行的专业人员数量无法跟上需要治疗的患者数量的增长。因此，即使拥有先进的设备，医疗机构的手术能力也受到限制，能够进行的手术数量也受到限制。

人才短缺直接影响市场收入，限制了新技术的普及，并延长了患者接受所需治疗的等待时间。当医院缺乏足够的合格人员时，已安装的系统无法充分利用，导致资本资产利用率低下，错失了商机。根据英国心臟基金会预测，到2024年，英格兰等待心臟检查和治疗的患者人数预计将达到约40万的历史新高，凸显了人才短缺的严重性。这些延误迫使医疗机构只能优先处理最紧急的病例，导致整体手术量下降，并抑制了全球对电生理设备的需求。

市场趋势

将人工智慧 (AI) 整合到心臟定位系统中，正从根本上改变全球电生理市场，显着提升诊断准确性和手术效率。製造商正将机器学习演算法融入标测平台，以自动识别复杂的心律不整基材，减少操作人员的手动操作，并提高讯号解读的准确性。这项技术突破实现了即时解剖建模和异位起搏点的快速识别，而这对于消融治疗的成功至关重要。根据 Biosense Webster 公司于 2024 年 5 月发布的「Carto 3 系统版本 8」的产品信息，该公司已推出其最新的标测软体「CartoSound FAM 模组」。此模组利用人工智慧自动产生左心房解剖结构，显着简化了心导管电气烧灼术手术的流程。

同时，降低医疗成本的需求正在加速电生理手术转移到门诊手术中心（ASC）的情况。随着心导管电气烧灼术安全性的提高，医疗系统正将常规手术从高成本的医院门诊转移到成本效益更高的门诊手术中心。这种转变的经济奖励来自于有利的报销机制，该机制在不影响临床品质的前提下优化了资源配置。根据心律介入学会2024年9月题为《门诊手术中心心臟电生理手术的安全性和可行性》的信函，美国医疗保险和医疗补助服务中心（CMS）的支付分析显示，在医院门诊部进行的心臟电生理手术的成本比在门诊手术中心进行的同类手术高出36%，这印证了推动这一转变的经济效益。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球电生理市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（电生理消融导管、电生理诊断导管、电生理检查室设备、通路装置）
  • 依适应症（心房颤动、心室性心搏过速、心房心搏过速、心房扑动、预激症候群（WPW）、房室结折返性心搏过速（AVNRT）、其他）
  • 按最终使用者（医院和心臟中心、门诊手术中心）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美电生理市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲电生理市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区电生理市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲电生理市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲电生理市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球电生理市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Johnson & Johnson Services, Inc.
• BIOTRONIK SE & Co KG
• Medtronic Plc.
• Boston Scientific Corporation
• B. Braun SE
• Koninklijke Philips NV
• Medline Industries, LP.
• Siemens Healthineers AG

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Electrophysiology Market is projected to expand from USD 9.38 Billion in 2025 to USD 19.11 Billion by 2031, achieving a compound annual growth rate of 12.59%. Electrophysiology is a specialized field within cardiology dedicated to diagnosing and treating heart rhythm disorders by analyzing the heart's electrical activity. The market primarily utilizes diagnostic catheters, ablation catheters, and mapping systems to correct arrhythmias like atrial fibrillation and restore normal cardiac function. This sector's growth is fundamentally driven by an aging global population and the increasing prevalence of chronic cardiac conditions requiring procedural intervention. For instance, the Heart Rhythm Society estimates that in 2025, atrial fibrillation will affect approximately 10.5 million adults in the United States, indicating a significant and growing patient base needing electrophysiological care.

However, a major obstacle hindering the rapid expansion of this market is the shortage of skilled electrophysiologists and specialized staff needed to perform these complex procedures. The extensive training required to master ablation techniques creates a workforce bottleneck that limits the number of treatments medical facilities can conduct annually. This scarcity of qualified personnel restricts patient access to life-saving therapies and constrains potential revenue growth for manufacturers and healthcare providers globally.

Market Driver

The escalating prevalence of atrial fibrillation (AFib) and cardiac arrhythmias acts as the primary catalyst for the Global Electrophysiology Market. As demographic shifts lead to an aging global population and lifestyle-related risk factors like hypertension increase, the incidence of complex rhythm disorders is surging. This expansion of the patient pool necessitates a higher volume of diagnostic and therapeutic interventions, thereby fueling demand for advanced ablation catheters and mapping systems. According to a May 2024 press release by Medtronic regarding the approval of its PulseSelect pulsed field ablation system in Japan, atrial fibrillation affects more than 60 million people worldwide, highlighting the critical need for effective electrophysiological solutions on a global scale.

Simultaneously, continuous product innovation and the acquisition of key regulatory clearances are accelerating market expansion by enhancing procedural safety and efficiency. The recent commercialization of Pulsed Field Ablation (PFA) technologies represents a significant shift, encouraging rapid adoption by healthcare facilities seeking to optimize clinical outcomes and patient turnover. This wave of technological advancement is translating into substantial financial gains for leading manufacturers as hospitals upgrade their laboratories. For instance, Boston Scientific reported in its 'Q3 2024 Financial & Operational Highlights' in October 2024 that its Electrophysiology business segment saw a 177% year-over-year net sales increase, driven by its novel ablation portfolio. Similarly, Abbott's electrophysiology division achieved organic sales growth of 14.3% in the third quarter of 2024, further evidencing the sector's upward trajectory.

Market Challenge

The shortage of skilled electrophysiologists and specialized laboratory staff presents a primary constraint on the market's trajectory. Electrophysiology procedures, particularly those involving ablation and mapping, are highly technical and require operators to undergo extensive and prolonged training to ensure patient safety and procedural success. This steep learning curve creates a rigid bottleneck in the workforce supply, as the rate at which new specialists enter the field fails to keep pace with the growing volume of patients requiring treatment. Consequently, medical facilities face a capped capacity for performing procedures, restricting the volume of interventions possible regardless of the availability of advanced equipment.

This labor deficit directly impacts market revenue by limiting the adoption rate of new technologies and extending patient wait times for necessary interventions. When hospitals lack sufficient qualified personnel, they cannot fully utilize installed systems, leading to underutilization of capital assets and missed revenue opportunities. According to the British Heart Foundation, in 2024, the number of people waiting for heart tests and treatments in England reached a record high of approximately 400,000, underscoring the critical workforce deficits. Such delays force healthcare providers to prioritize only the most critical cases, thereby slowing the overall procedural volume and tempering the demand for electrophysiology devices globally.

Market Trends

The Integration of Artificial Intelligence in Cardiac Mapping Systems is fundamentally reshaping the Global Electrophysiology Market by enhancing diagnostic precision and procedural efficiency. Manufacturers are embedding machine learning algorithms into mapping platforms to automate the identification of complex arrhythmia substrates, reducing operator manual workload and interpreting signal data with greater accuracy. This technological leap allows for real-time anatomical modeling and faster localization of ectopic foci, which is critical for successful ablation outcomes. According to Biosense Webster's May 2024 product announcement for the 'Carto 3 System Version 8', the company launched its latest mapping software featuring the CartoSound FAM module, which utilizes artificial intelligence to automatically generate left atrial anatomy and significantly streamline the workflow for catheter ablation procedures.

Concurrently, the Shift of Electrophysiology Procedures to Ambulatory Surgical Centers (ASCs) is accelerating, driven by the imperative to reduce healthcare expenditures. As safety profiles for catheter ablations improve, healthcare systems are migrating routine interventions from high-cost hospital outpatient departments to cost-effective ASC environments. This transition is financially incentivized by favorable reimbursement structures that optimize resource allocation without compromising clinical quality. According to a September 2024 letter from the Arrhythmia Intervention Society titled 'Safety and Feasibility of Cardiac Electrophysiology Procedures In Ambulatory Surgery Centers', an analysis of CMS payments revealed that cardiac electrophysiology procedures performed in hospital outpatient departments incurred a 36% cost increase compared to those conducted in ambulatory surgical centers, underscoring the economic benefits fueling this shift.

Key Market Players

• Johnson & Johnson Services, Inc.
• BIOTRONIK SE & Co KG
• Medtronic Plc.
• Boston Scientific Corporation
• B. Braun SE
• Koninklijke Philips N.V.
• Medline Industries, LP.
• Siemens Healthineers AG

Report Scope

In this report, the Global Electrophysiology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Electrophysiology Market, By Product

• Electrophysiology Ablation Catheters
• Electrophysiology Diagnostic Catheters
• Electrophysiology Laboratory Devices
• Access Devices

Electrophysiology Market, By Indication

• Atrial Fibrillation
• Ventricular Tachycardia
• Atrial Tachycardia
• Atrial Flutter
• WOLFF-Parkinson-White (WPW) Syndrome
• Atrioventricular Nodal Reentry Tachycardia (AVNRT)
• Others

Electrophysiology Market, By End User

• Hospitals and Cardiac Centres
• Ambulatory Surgery Centres

Electrophysiology Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Electrophysiology Market.

Available Customizations:

Global Electrophysiology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Electrophysiology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Laboratory Devices, Access Devices)
  • 5.2.2. By Indication (Atrial Fibrillation, Ventricular Tachycardia, Atrial Tachycardia, Atrial Flutter, WOLFF-Parkinson-White (WPW) Syndrome, Atrioventricular Nodal Reentry Tachycardia (AVNRT), Others)
  • 5.2.3. By End User (Hospitals and Cardiac Centres, Ambulatory Surgery Centres)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Electrophysiology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Indication
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Electrophysiology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Electrophysiology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Electrophysiology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By End User

7. Europe Electrophysiology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Indication
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Electrophysiology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By End User
  • 7.3.2. France Electrophysiology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Electrophysiology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Electrophysiology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Electrophysiology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By End User

8. Asia Pacific Electrophysiology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Indication
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Electrophysiology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By End User
  • 8.3.2. India Electrophysiology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Electrophysiology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Electrophysiology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Electrophysiology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By End User

9. Middle East & Africa Electrophysiology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Indication
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Electrophysiology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Electrophysiology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Electrophysiology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By End User

10. South America Electrophysiology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Indication
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Electrophysiology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Electrophysiology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Electrophysiology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Electrophysiology Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Johnson & Johnson Services, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. BIOTRONIK SE & Co KG
• 15.3. Medtronic Plc.
• 15.4. Boston Scientific Corporation
• 15.5. B. Braun SE
• 15.6. Koninklijke Philips N.V.
• 15.7. Medline Industries, LP.
• 15.8. Siemens Healthineers AG

16. Strategic Recommendations

17. About Us & Disclaimer